Accumen, which assists organizations with outreach services, imaging, clinical laboratory operations and patient blood management, has scooped up Pennsylvania-based Halfpenny for an undisclosed amount.
At MedCity ENGAGE on November 7, leaders from Dignity Health and UC San Diego Health discussed challenges to IT adoption as well as how technology can benefit patients and clinicians.
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
During a November 6 breakout session at MedCity ENGAGE, panelists shared that patients should be their own advocates, be part of their care team and stay informed.
Rady Children's Institute for Genomic Medicine is using rapid whole-genome sequencing to transform the lives of children and babies. President and CEO Stephen Kingsmore, who will be speaking at MedCity ENGAGE, discussed how.
Menlo Park, California-based HighBar Partners led the round. Psilos Group, TPG, Camden Partners and Merck Global Health Innovation Fund also participated.
A healthy dose of competition has been injected into the market for life-saving emergency epinephrine injectors.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
The development of type 1 diabetes starts years before symptoms appear, which raises the possibility of early intervention, prevention, or possibly even reversal of the disease. Such efforts were discussed on Monday at the American Diabetes Association's Scientific Sessions.
Former Google Ventures (GV) CEO Bill Maris is reportedly about to close on a $100 million San Diego-based venture fund, for which he is the sole investor. The catch? This story has played out before.
Washington University spin-out PvP Biologics has bypassed traditional seed financing, jumping straight into a development agreement with Takeda Pharmaceuticals to further its investigational therapy for celiac disease.
Bill Maris, who cofounded GV (formerly Google Ventures) and led the firm from 2009 until earlier this year, is rumored to be setting up shop in San Diego with a new $230 million healthcare fund.
CEO and neuroscientist Dr. Iftach Dolev on how the new device can bring a powerful tool to psychiatrists and neurologists alike.